You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
A Blubber or Dorsal Fin Piercing Tag Attachment System for Remotely-Deployed Cetacean Tags
SBC: American Benchmark Machine Works Topic: 824Animal-borne electronic instruments (tags) are critical tools for monitoring the behavior and ecology of cetaceans, providing data needed for managing their populations and mitigating the threats they face. Although remote-deployment of tags onto cetaceans that cannot be captured has provided valuable data, attachment durations have been frustratingly short and variable. Our Phase II goal is to de ...
SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration -
Bottom Feeder- A Highly Maneuverable Autonomous Underwater Vehicle
SBC: Tridentis Advanced Marine Vehicles LLC Topic: 822The Bottom Feeder project is designed to prove out the research done in Phase I using a prototype platform. The prototype will be a full size version of the platform designed during Phase I. The Phase I platform was designed to work in two operational configurations, a highly efficient mode and a highly maneuverable mode, with the ability to switch between them while submerged. The platform is equ ...
SBIR Phase II 2019 Department of CommerceNational Oceanic and Atmospheric Administration -
Development of a Prophylactic Onchocerciasis Vaccine
SBC: PAI LIFE SCIENCES INC Topic: NIAIDHumanriver blindnessis caused by a filarial parasite and is a serious neglected tropical disease contributing to blindnessskin diseaseand chronic disability in the developing worldEstimates from the Global Burden of Disease Studyindicate thatmillion cases of onchocerciasisleading tomillion cases of vision impairmentoccur worldwide every yearThe goal of this project is to develop a safe and effecti ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Improving Spatiotemporal Precision in Noninvasive Electrical Neuromodulation
SBC: Brain Electrophysiology Laboratory Company, LLC Topic: 101This application describes the commercialization of the Geodesic Transcranial Electrical Neuromodulation (GTEN) technology to achieve noninvasive neuromodulation with improved spatiotemporal precision. The GTEN system enables both EEG source analysis and configurable electrical neuromodulation with the 256 electrodes of the Geodesic Sensor Net. Now in beta release to selected research customers, t ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Whole-organ bioreactor with integrated nondestructive 3D molecular imaging
SBC: Sonovol, Inc. Topic: NHLBIAbstract Significance: Donor tissue shortage remains a critical problem in lung transplantation. Recent advances in tissue engineering have allowed for the possibility of generating bioengineered lungs from decellularized organ scaffolds. These scaffolds, created from the donor’s tissue, become functionalized after recellularization with a patient’s own cells. However, translation of whole-lun ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
High Throughput CRISPR/Cas9 cell line generation using the CellRaft Array
SBC: CELL MICROSYSTEMS INC Topic: 400Project SummaryGenome editing technologies, such as CRISPR/Cas9 provide a rapid, and targeted means of both knocking out gene expression and knocking in gene modifications. Since our initial Phase I submission, the utility of CRISPR technology has expanded beyond the generation of cell lines, to forward genetic screening, in vivo manipulation of gene expression and even human therapeutics. Phase I ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients
SBC: LUMITHERA INC Topic: NEIAs the population continues to age, degenerative ocular diseases become increasingly common and create a tremendous burden on the health care system. Age-related macular degeneration (AMD) represents a significant problem with 10-11 million patients at risk to progress to severe vision loss in the U.S. alone and the prevalence of AMD is expected to double by 2020. The dry and wet forms of the dise ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Silicon Photonic Blood Typing
SBC: SiDx, Inc. Topic: NHLBISUMMARY Millions of blood samples are tested annually to establish blood type compatibility between blood donors and transfusion recipients. However, current testing methods are encumbered by the need for large blood samples, transportation to centralized laboratories, time to centrifuge and perform testing, specialized reagents, and technical training needs, placing a costly burden on the medical ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Clinical Evaluation of an Innovative PSMA-targeted Radiotherapy, CTT1403, in Prostate Cancer
SBC: Cancer Targeted Technology LLC Topic: 102PROJECT ABSTRACT Prostate-Specific Membrane Antigen (PSMA) is an ideal tumor biomarker as it is expressed on andgt;90% of all prostate cancers and expression increases as the cancer progresses. Cancer Targeted Technology (CTT) has developed a unique phosphoramidate-based scaffold that binds irreversibly to PSMA leading to andgt; 90% rapid internalization and selective accumulation in tumor cells. ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT
SBC: Elex Biotech, Inc Topic: NHLBIPROJECT SUMMARY The goal of this project is to complete the preclinical development of Elex Biotechandapos;s novel compounds that target and treat the underlying molecular cause of catecholaminergic polymorphic ventricular tachycardia (CPVT) CPVT. There are no FDA-approved treatments for CPVT, a rare genetic disorder affecting 1/10,000 individuals, with typical onset in children 7-9 years of age a ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health